Cargando…
Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2
Coronavirus disease 2019 (COVID-19) caused by “Severe Acute Respiratory Syndrome Coronavirus-2” (SARS-CoV-2) infection emerged in Wuhan, a city of China, and spread to the entire planet in early 2020. The virus enters the respiratory tract cells and other tissues via ACE2 receptors. Approximately 20...
Autor principal: | Pamukçu, Burak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585960/ https://www.ncbi.nlm.nih.gov/pubmed/33001051 http://dx.doi.org/10.14744/AnatolJCardiol.2020.56727 |
Ejemplares similares
-
Mechanisms and management of prothrombotic state in COVID-19
disease
por: Acherjee, Trishna, et al.
Publicado: (2021) -
Prothrombotic Phenotype in COVID-19: Focus on Platelets
por: Barale, Cristina, et al.
Publicado: (2021) -
Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes()
por: Páramo, José A.
Publicado: (2022) -
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
por: Lopez-Castaneda, Sandra, et al.
Publicado: (2021) -
The underrecognized prothrombotic vascular disease of COVID‐19
por: Cohoon, Kevin P., et al.
Publicado: (2020)